The Leukemia Division, established in 2000, has had a seminal role in the development of novel therapies for several types of leukemia, particularly chronic myeloid leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and myelodysplasia.

The leukemia team together with outstanding hematopathologists, infectious disease specialists, a research-dedicated team, as well as one of the largest bone marrow transplant programs in the world, is able to provide options for all patients with leukemia including the most challenging cases where patients have failed prior therapy.Leukemias-Principles-and-Practice-of-Therapy

Dr Stuart Goldberg has been a pioneer, particularly in CML and MDS and the founder of the Leukemia Division. Dr Stefan Faderl, after 16 years at MD Anderson, Houston, TX, as a Professor of Medicine in the largest Leukemia Program in the world, joined us in 2014 to lead JTCC Leukemia Program. He is an internationally known investigator in the field and has authored the most recent comprehensive book on leukemia.

The Leukemia Division Team

RCCA0131

STEFAN FADERL, M.D.
Chief, Leukemia

READ BIO

RCCA0131

STUART L. GOLDBERG, M.D
Attending, Leukemia, Chief Medical Officer, COTA

READ BIO

RCCA0131

JAMIE L. KOPRIVNIKAR, M.D.
Hematologist/Oncologist, Leukemia

READ BIO

RCCA0131

JAMES K. MCCLOSKEY II, M.D.
Hematologist/Oncologist, Leukemia

READ BIO

Pathology

Pritish Bhattacharyya, M.D.
Kar Fai (David) Chow, M.D.
Patrice Hassoun, M.D.
Xiao Yan Yang, M.D.

Advanced Practice Nurse/Nurse Practitioner

Samantha DePadova
Rosemarie Wellman
Beth Jones
Grace Perry
Genique Stanislaus
Beth Boseski
Gabby Maggarelli

Research Nurses

Gillian Velardi
Michelle Borza
Kevin Barga

Oncology Nurse Navigator

Tara Dugan

Social Work Support Services

Elaine Dombrowski, L.C.S.W.

Call for an appointment

Hackensack: 551-996-5900
Palisades: 201-464-0008

To reach the extensions of Drs. McCloskey, Faderl and Koprivnikar please dial ext. 3925.